Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuele Ferrari

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Respiratory Research|August 21, 2022
Diaphragm ultrasound evaluation during weaning from mechanical ventilation in COVID-19 patients: a pragmatic, cross-section, multicenter studyLuigi Vetrugno, Daniele Orso, Francesco Corradi, et al.
Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.
Cell Reports. Medicine|November 13, 2024
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cellsLucrezia Della Volpe, Federico Midena, Roberta Vacca, et al.
Cell Stem Cell|October 7, 2022
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cellsSamuele Ferrari, Aurelien Jacob, Daniela Cesana, et al.
Research Square|February 26, 2024
Metformin reduces the clonal fitness of <i>Dnmt3a</i> <sup>R878H</sup> hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Nature|April 16, 2025
Metformin reduces the competitive advantage of Dnmt3a<sup>R878H</sup> HSPCsMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Cell Stem Cell|January 9, 2026
Nanoengineered 3D culture substrate enables superior persistence and polyclonal engraftment of genetically engineered hematopoietic stem cellsFederico Midena, Laura Alessandrini, Claudio Conci, et al.
Nature Medicine|April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Nature Communications|January 8, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Respiratory Research|August 21, 2022
Diaphragm ultrasound evaluation during weaning from mechanical ventilation in COVID-19 patients: a pragmatic, cross-section, multicenter studyLuigi Vetrugno, Daniele Orso, Francesco Corradi, et al.
Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.
Cell Reports. Medicine|November 13, 2024
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cellsLucrezia Della Volpe, Federico Midena, Roberta Vacca, et al.
Cell Stem Cell|October 7, 2022
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cellsSamuele Ferrari, Aurelien Jacob, Daniela Cesana, et al.
Research Square|February 26, 2024
Metformin reduces the clonal fitness of <i>Dnmt3a</i> <sup>R878H</sup> hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic stateMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Nature|April 16, 2025
Metformin reduces the competitive advantage of Dnmt3a<sup>R878H</sup> HSPCsMohsen Hosseini, Veronique Voisin, Ali Chegini, et al.
Cell Stem Cell|January 9, 2026
Nanoengineered 3D culture substrate enables superior persistence and polyclonal engraftment of genetically engineered hematopoietic stem cellsFederico Midena, Laura Alessandrini, Claudio Conci, et al.
Nature Medicine|April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndromeRaffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Nature Communications|January 8, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strengthMartina Spiga, Alessia Potenza, Zulma Magnani, et al.
Pageof 3